Inventor · disambiguated record
Junming Yie
Also filed as: YIE JUNMING
8 granted patents·6 pending applications·129 citations·filing 2006–2025
86Inventor score
Top patents by PatentIndex Score
14 records- 0192US7807159B2Antibodies to myostatinAMGEN FREMONT INC·Filed 2006·Granted Oct 5, 2010·102 cites·14 claims
- 0291US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 0390US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0486US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 0586US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 0681US11248052B2Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorAMGEN INC·Filed 2019·Granted Feb 15, 2022·1 cites·5 claims
- 0780US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 0876US9574002B2Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorLI YANG·Filed 2012·Granted Feb 21, 2017·2 cites·14 claims
- 0971US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 1069US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 1154US2024255492A1Functional cell-based potency assay for measuring biological activity of interleukin 2 (il-2) analogsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1252US2017183412A1Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF ReceptorAMGEN INC·Filed 2017·Application pending·0 cites
- 1351US2022026414A1Cell-based bioidentity test for insulinMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 1439US2011091455A1Antibodies to myostatinAMGEN FREMONT INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Junming Yie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →